Fox Run Management, L.L.C. Deciphera Pharmaceuticals, Inc. Transaction History

Fox Run Management, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$10.11 - $16.54 $122,745 - $200,812	-12,141 Reduced 53.86%	10,399 $167,000
Q3 2023 Nov 07, 2023	BUY	$12.46 - $15.48 $280,848 - $348,919	22,540 New	22,540 $286,000
Q1 2023 May 12, 2023	BUY	$14.26 - $22.1 $360,036 - $557,980	25,248 New	25,248 $390,000
Q3 2022 Nov 07, 2022	BUY	$12.38 - $20.23 $171,760 - $280,671	13,874 Added 133.07%	24,300 $450,000
Q2 2022 Aug 12, 2022	BUY	$9.11 - $13.98 $94,980 - $145,755	10,426 New	10,426 $137,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.